Lacosamide NDC 70518-4562

Product information

Brand name (proprietary)

Lacosamide

Generic name (nonproprietary)

lacosamide

Active ingredients

Lacosamide — 100 mg/1

Dosage form

Tablet, Film coated

Route

Oral

Labeler

REMEDYREPACK INC.

Product type

Prescription drug

Marketing category

ANDA — Abbreviated New Drug Application (generic)Application ANDA 205237

Marketing start

Feb 2, 2026

Listing expires

Dec 31, 2027

DEA schedule

CV

Other FDA classes

Decreased Central Nervous System Disorganized Electrical Activity (Physiologic effect)

Identifiers

Product ID 70518-4562_5b9f43a0-95ad-1717-e063-6294a90adbdcSPL ID 5b9f43a0-95ad-1717-e063-6294a90adbdc

Billing references

What Med-Code can say about coding this product, and where each statement comes from. Nothing here is inferred from the name alone.

HCPCS codeNo match

No HCPCS code in Med-Code's directory. Oral products like this are usually dispensed by a pharmacy and billed by NDC.

NDC on a medical claim

N470518456200 followed by a unit qualifier and the quantity Copy

Package 70518-4562-00. Unit qualifiers: F2 (international unit), GR (gram), ME (milligram), ML (milliliter), UN (unit (each)). The qualifier and quantity depend on what was given. About the N4 qualifier

Product label

The FDA listing for this product does not reference a label (SPL) set.

Other NDCs under ANDA 205237

Products listed under the same FDA application: other strengths and forms, and repackagers who relabel the same product.